TELA Bio (TELA) Net Equity Issued and Repurchased (2020 - 2023)

TELA Bio has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at -$13000.0 in Q3 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$13000.0 in Q3 2023; TTM through Dec 2023 was $46.0 million, a 49.28% decrease from a year earlier, with the FY2023 full-year figure at $46.3 million, up 34.71% from the prior year.
• Net Equity Issued and Repurchased was -$13000.0 for Q3 2023 at TELA Bio, down from $46.3 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $46.3 million in Q2 2022, with the low at -$275000.0 in Q4 2022.
• Average Net Equity Issued and Repurchased over 3 years is $27.4 million, with a median of $44.7 million recorded in 2020.
• The largest YoY upside for Net Equity Issued and Repurchased was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
• Over 3 years, Net Equity Issued and Repurchased stood at $44.7 million in 2020, then slumped by 100.62% to -$275000.0 in 2022, then soared by 95.27% to -$13000.0 in 2023.
• The last three Net Equity Issued and Repurchased figures came in at -$13000.0 (Q3 2023), $46.3 million (Q2 2023), and -$275000.0 (Q4 2022), per Business Quant data.